RecruitingACTRN12623000341628

Use of Nasogastric Tubes in Adult Patients with Small Bowel Obstruction

A Randomised Clinical Trial to Assess the Use of Nasogastric Tubes in Adult Patients with Adhesive Small Bowel Obstruction for Prevention of Operative Intervention.


Sponsor

Hunter New England Local Health District

Enrollment

480 participants

Start Date

Nov 1, 2023

Study Type

Interventional

Conditions

Summary

This study looks at the use of the nasogastric tube in the management of small bowel obstruction in patients with a history of abdominal surgery. The null hypothesis is that not using the nasogatric tube results in an more operations than the nasogastric tube. Small bowel obstruction is a surgical emergency and at its worst can result in the death of a patient due to small bowel infarction. The accepted standard of care is insertion of a nasogastric tube to decompress a distended stomach. There is little if any research evidence to support this practice and this study seeks to compare this practice to not using a nasogastric tube and observe if it results in less patients having srugery to the condition.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

A small bowel obstruction is a blockage in the small intestine, usually caused by scar tissue (adhesions) from previous abdominal surgery. It is a medical emergency that causes severe abdominal pain, bloating, nausea, and vomiting. Current standard management involves inserting a nasogastric (NG) tube through the nose and down into the stomach to decompress the bowel by draining accumulated fluid and air. However, there is surprisingly little research evidence proving that this NG tube actually helps patients avoid surgery or recover faster. This randomised controlled trial is comparing two approaches in patients admitted to hospital with a small bowel obstruction after previous abdominal surgery: one group receives the standard NG tube treatment, while the other group is managed without the NG tube. The study will measure how many patients in each group ultimately need surgery, how long they stay in hospital, and how their recovery compares. You may be eligible if you are 18 or older, have had previous abdominal surgery, have arrived directly from home, and an X-ray or CT scan confirms a small bowel obstruction. People with known cancer-related blockages, hernias causing obstruction, signs of bowel dying, or who have already had a tube inserted would not be eligible.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

No nasogastric tube, in addition to standard care which may include intravenous fluids, analgesia, anti-emetics, and/or surgery as determined by surgeon in charge based on progress of signs and sympto

No nasogastric tube, in addition to standard care which may include intravenous fluids, analgesia, anti-emetics, and/or surgery as determined by surgeon in charge based on progress of signs and symptoms of bowel onstruction including radiological changes. Adherence to ransomisation will be recorded from the medical record.


Locations(2)

John Hunter Hospital - New Lambton

NSW, Australia

Calvary Mater Newcastle - Waratah

NSW, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12623000341628